Résumé
Activating immune cells to destroy tumours is an effective strategy for treating an advanced lung cancer - but only for some people. Evidence that this approach has potential in early disease and as a combination therapy has now emerged.
langue originale | Anglais |
---|---|
Pages (de - à) | 1-2 |
Nombre de pages | 2 |
journal | Nature |
Volume | 558 |
Numéro de publication | 7710 |
Les DOIs | |
état | Publié - 21 juin 2018 |
Modification externe | Oui |